Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

Quality of life data from randomized trials are lacking in older patients with metastatic colorectal cancer (mCRC). In the randomized NORDIC9-study, reduced-dose S1+oxaliplatin (SOx) showed superior efficacy compared to full-dose S1 monotherapy. We hypothesized that treatment with SOx does not resul...

Full description

Bibliographic Details
Main Authors: Gabor Liposits, Henrik Rode Eshøj, Sören Möller, Stine Brændegaard Winther, Halla Skuladottir, Jesper Ryg, Eva Hofsli, Carl-Henrik Shah, Laurids Østergaard Poulsen, Åke Berglund, Camilla Qvortrup, Pia Österlund, Bengt Glimelius, Halfdan Sorbye, Per Pfeiffer
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
older adults
metastatic colorectal cancer
chemotherapy
vulnerability
quality of life
physical functioning
Online Access:https://www.mdpi.com/2072-6694/13/11/2604

Internet

https://www.mdpi.com/2072-6694/13/11/2604

Similar Items